Rising market volatility has pushed dividend-paying stocks back into focus. Investors often turn to these names when markets get rough.

Amerant faces margin pressure from high deposit costs and real estate exposure, despite strategic risk reduction and asset quality improvements. Potential upside exists, with fair value estimated at ...

The U.S. biotechnology market enters 2026 as the largest global biotech market, with an estimated size of $552.39 billion in 2023, and is projected to grow to $1.24 trillion by 2030.